Acadia Healthcare Company, Inc. (ACHC) 2016 Q2 法說會逐字稿

完整原文

使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主

  • Brent Turner - President

    Brent Turner - President

  • Good morning, I am Brent Turner, President of Acadia Healthcare Company, and I would like to welcome you to our second quarter 2016 conference call. To the extent any non-GAAP financial measure is discussed in today's call, you will also find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP on our website, by viewing this morning's news release under the Investors link. This conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements among others, regarding Acadia's expected quarterly and annual financial performance for 2016 and beyond.

    各位早安,我是 Acadia Healthcare Company 總裁 Brent Turner,歡迎各位參加我們 2016 年第二季電話會議。就今日電話會議中所討論之任何非 GAAP 財務衡量指標而言,您亦可在我們網站上,透過投資人(Investors)連結查看今早新聞稿,以取得該指標與依 GAAP 計算之最直接可比財務衡量指標之調節表。本次電話會議可能包含《1995 年私人證券訴訟改革法》(Private Securities Litigation Reform Act of 1995)所定義之前瞻性陳述,包括但不限於關於 Acadia 對 2016 年及其後預期之季度與年度財務表現的陳述。

  • For this purpose, any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words believes, anticipates, plans, expects, and similar expressions are intended to identify forward-looking statements. You are hereby cautioned that these statements may be affected by the important factors among others, set forth in Acadia's filings with the Securities and Exchange Commission, and in the Company's second quarter news release, and consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements.

    基於此目的,本次電話會議中任何非歷史事實之陳述,均可能被視為前瞻性陳述。在不限制前述內容之前提下,「相信」、「預期」、「計畫」、「期望」及類似用語旨在辨識前瞻性陳述。特此提醒您,這些陳述可能受到若干重要因素(包括但不限於)之影響,該等因素載於 Acadia 向美國證券交易委員會(Securities and Exchange Commission)提交之文件以及本公司第二季新聞稿中;因此,實際營運與結果可能與前瞻性陳述中所討論之結果存在重大差異。

  • The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events, or otherwise. At this time for opening remarks, I would like to turn the conference over to our Chairman and Chief Executive Officer, Joey Jacobs.

    本公司不承擔公開更新任何前瞻性陳述之義務,不論係因新資訊、未來事件或其他原因。接下來進入開場致詞,我想將會議交給我們的董事長兼執行長 Joey Jacobs。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Good morning and welcome to our second quarter conference call. In addition to Brent, I am here today with our Chief Financial Officer, David Duckworth, and other members of our Executive management team. David and I each have some brief remarks about the second quarter and outlook for Acadia, then we'll open the line for your questions.

    各位早安,歡迎參加我們第二季電話會議。除了 Brent 之外,今天與我一同出席的還有我們的財務長 David Duckworth,以及其他執行管理團隊成員。David 和我將各自就第二季表現與 Acadia 的展望做一些簡短說明,之後我們將開放線路回答各位的提問。

  • Before we discuss the quarter, let me briefly touch on the announcement yesterday by the competition and the market authority in the United Kingdom, that in lieu of a Phase II investigation, we have offered undertakings to address CMA's concerns. Our undertakings provide for the sale of 19 of our Priory and PiC healthcare facilities, with approximately 750 beds. These facilities produced aggregate annual revenue of approximately $132 million, and adjusted EBITDA of $39 million. Before any overhead allocation, and assuming an exchange rate of $1.30 per British pound sterling. We expect to see the CMA to accept our undertaking and approve the priority acquisitions in the next two to four months. Turning now to our second quarter results, we achieved another quarter of profitable growth, our revenue increased 67% for the quarter, versus the second quarter last year, which is the sixth consecutive quarter our revenue has grown at a rate of more than 60%. Adjusted earnings also rose 60% for the quarter. Our adjusted earnings per diluted share of $0.73, increased 28.1% on a 26.4% increase in shares outstanding. We attribute this growth to the strong continuing execution of our acquisitions and organic growth strategy. Through which we are expanding Acadia's ability to meet increasing demand for our services. These strategies have enabled us to expand our beds over the last 12 months by almost 100%, to approximately 17,800 beds. While acquisitions and specifically the Priory acquisition accounted for the great majority of our bed expansion, we also added over 940 beds during the last 12 months. Approximately 680 of these beds were additions to existing facilities, and 260 beds were added through the opening of three de novo facilities. During the second quarter we added 125 new beds to facilities in the US and the UK, and opened a de novo facility with 60 beds. This brings the number of bed additions to 515 in the first half of 2016, and we expect to add more than 800 beds for the year. Bed additions to existing facilities drive our overall organic growth, including our same facility revenue, which increased 8.1% for the quarter. We have continued to benefit from the operating leverage that this same facility revenue growth generates, with the same facility EBITDA margin increasing to 28.1% for the second quarter.

    在討論本季之前,我先簡要提及昨日英國競爭對手與市場主管機關的公告:為取代第二階段(Phase II)調查,我們已提出承諾(undertakings)以回應 CMA 的疑慮。我們的承諾包括出售 19 家 Priory 與 PiC 醫療照護機構,約 750 張床位。這些機構合計年營收約 1.32 億美元,調整後 EBITDA 為 3,900 萬美元(未分攤任何管理費用,並假設匯率為每 1 英鎊兌 1.30 美元)。我們預期 CMA 將接受我們的承諾,並在未來二至四個月內核准 Priory 併購案。接著談第二季業績,我們再度達成獲利成長,本季營收較去年第二季成長 67%,這是我們連續第六季營收成長率超過 60%。調整後獲利本季亦成長 60%。我們的稀釋後每股調整後盈餘為 0.73 美元,在流通在外股數增加 26.4% 的情況下,仍成長 28.1%。我們將此成長歸因於持續強勁地執行併購與有機成長策略,藉此擴大 Acadia 滿足服務需求增加的能力。這些策略使我們在過去 12 個月內床位數幾乎增加 100%,至約 17,800 張床位。雖然併購(尤其是 Priory 併購)占了床位擴張的絕大部分,我們在過去 12 個月也新增超過 940 張床位,其中約 680 張為既有機構擴建新增,另有 260 張來自三家新設(de novo)機構的開業。第二季期間,我們在美國與英國的機構新增 125 張床位,並開設一家擁有 60 張床位的新設機構。這使得 2016 年上半年床位新增數達到 515 張,我們預期全年新增床位將超過 800 張。既有機構的床位新增帶動我們整體有機成長,包括同店營收(same facility revenue),本季成長 8.1%。我們亦持續受惠於同店營收成長所帶來的營運槓桿效益,使同店 EBITDA 利潤率於第二季提升至 28.1%。

  • We have also remained active on the acquisition front during the second quarter. We completed four acquisitions in the US, with approximately 240 beds including an acute psychiatric inpatient facility, two residential addiction treatment facilities, and a comprehensive treatment facility, or CTC. We continue to evaluate additional transactions and a robust pipeline of potential transactions, and we are confident of our ability to fund appropriate transactions.

    第二季我們在併購方面亦保持活躍。我們在美國完成四項併購,合計約 240 張床位,包括一家急性精神科住院機構、兩家成癮住宅治療機構,以及一家綜合治療機構(comprehensive treatment facility,或稱 CTC)。我們持續評估其他交易以及強勁的潛在交易管線,並對我們為合適交易提供資金的能力充滿信心。

  • In summary, we have been very pleased with Acadia's execution of its growth strategy, and we're optimistic about our potential for producing continued long-term profitable growth. We are a diversified behavioral healthcare provider, and a leader in markets with growing demand and limited capacity. This increasing demand is being driven by strong demographics, as well as changing regulations that increase parity and access. We are developing an outstanding record of investing in expansions to meet the demands of our local communities which drive our organic growth. We also have a long history of growth through successfully acquiring and integrating transactions, in an industry that remains highly fragmented. Thank you for your interest in Acadia, and now I'll turn it over to David Duckworth.

    總結而言,我們對 Acadia 成長策略的執行成果感到非常滿意,並對持續創造長期獲利成長的潛力保持樂觀。我們是多元化的行為健康照護(behavioral healthcare)服務提供者,並在需求成長且供給有限的市場中居於領先地位。需求增加係由強勁的人口結構趨勢,以及提升同等給付與可近性(parity and access)的法規變化所驅動。我們在投資擴建以滿足在地社區需求方面建立了卓越的紀錄,進而推動我們的有機成長。我們亦在一個仍高度分散的產業中,長期透過成功併購與整合交易來實現成長。感謝各位對 Acadia 的關注,接下來我將交給 David Duckworth。

  • David Duckworth - CFO

    David Duckworth - CFO

  • Thanks Joey, and good morning. Acadia's revenue for the second quarter of 2016 increased 66.8% to $756.5 million, from $453.7 million for the second quarter of 2015. Adjusted income from continuing operations attributable to Acadia's stockholders was $63.2 million, up 60% from $39.5 million. Adjusted EPS for the second quarter of 2016 was $0.73, up 28.1% from $0.57 for the second quarter of 2015. For the second quarter of 2016, our adjusted EPS excludes transaction-related expenses of $6.1 million, and a gain on foreign currency derivatives of approximately $100,000. For the second quarter of 2015, adjusted EPS excludes transaction-related expenses of $7.2 million, and a loss on foreign currency derivatives of approximately $960,000. Weighted average diluted shares outstanding increased 26.4% for the comparable quarters, primarily due to the equity that we issued in May of 2015, that was principally related to acquisitions, and in January and February of 2016 related to the acquisition of Priory. Acadia's tax rate on adjusted income from continuing operations before income taxes was 21.7% for the second quarter of 2016, compared with 31.3% for the second quarter of last year. Acadia's same-facility revenue increased 8.1% from the second quarter of 2015, with a 7.7% increase in patient days, and a 0.4% increase in revenue per patient day. Same-facility EBITDA margin was 28.1% for the latest quarter, versus 27.4% for the second quarter of 2015. Consolidated adjusted EBITDA increased 62.8% to $172.2 million, which was 22.8% of consolidated revenue from $105.8 million, or 23.3% of consolidated revenue for the second quarter of 2015. Our operating cash flow increased 74.6% to $126.5 million in the second quarter of 2016, which is a quarterly record for operating cash flow.

    謝謝 Joey,各位早安。Acadia 2016 年第二季營收較 2015 年第二季的 4.537 億美元成長 66.8%,至 7.565 億美元。歸屬於 Acadia 股東之持續營運調整後淨利為 6,320 萬美元,較 3,950 萬美元成長 60%。2016 年第二季調整後每股盈餘(Adjusted EPS)為 0.73 美元,較 2015 年第二季的 0.57 美元成長 28.1%。2016 年第二季的調整後 EPS 排除與交易相關費用 610 萬美元,以及外匯衍生性金融工具收益約 10 萬美元。2015 年第二季的調整後 EPS 排除與交易相關費用 720 萬美元,以及外匯衍生性金融工具損失約 96 萬美元。可比季度的加權平均稀釋後流通在外股數增加 26.4%,主要係因我們於 2015 年 5 月發行之股權(主要與併購相關),以及於 2016 年 1 月與 2 月為 Priory 併購案所發行之股權。Acadia 以所得稅前之持續營運調整後淨利計算之稅率,2016 年第二季為 21.7%,相較去年第二季為 31.3%。Acadia 的同店營收較 2015 年第二季成長 8.1%,其中病患日數(patient days)增加 7.7%,每病患日營收增加 0.4%。最新季度同店 EBITDA 利潤率為 28.1%,相較 2015 年第二季為 27.4%。合併調整後 EBITDA 成長 62.8% 至 1.722 億美元,占合併營收 22.8%,相較 2015 年第二季為 1.058 億美元(占合併營收 23.3%)。我們的營運現金流於 2016 年第二季成長 74.6% 至 1.265 億美元,創下單季營運現金流新高。

  • Finally, as announced in this morning's news release, we have updated our guidance for 2016 adjusted earnings per diluted share to a range of $2.63 to $2.65. This adjustment is primarily a result of the decline in the US dollar to British Pound sterling exchange rate, as well as the delay in realizing false synergies due to the CMA's approval process. Our guidance assumes an exchange rate of $1.30 per British pound sterling for the second half of 2016, and a tax rate of 23%.

    最後,如同今早新聞稿所公告,我們已更新 2016 年稀釋後每股調整後盈餘指引區間至 2.63 至 2.65 美元。此調整主要係因美元兌英鎊匯率下滑,以及因 CMA 核准流程導致延後實現原先預期的協同效益。我們的指引假設 2016 年下半年匯率為每 1 英鎊兌 1.30 美元,稅率為 23%。

  • Our financial guidance does not include any cost synergies in 2016 from the Priory transaction, the impact from any future acquisitions, or transaction-related expenses. This concludes our prepared remarks this morning, and thank you for being us. I'll now ask Mia to open the floor for your questions.

    我們的財務指引未包含 2016 年 Priory 交易所帶來的任何成本協同效益、任何未來併購的影響,或與交易相關的費用。以上為我們今早的預先準備發言,感謝各位與會。接下來我將請 Mia 開放提問。

  • Operator

    Operator

  • Thank you sir. (Operator Instructions). We do ask that your limit yourself to one question and one follow-up question. And we will go first to Brian Tanquilut with Jefferies.

    謝謝您,先生。(接線員指示)。我們確實請您將問題限制為一個問題以及一個追問。接下來我們先請 Jefferies 的 Brian Tanquilut。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Hey, good morning guys, and congratulations. First question for David or Brent, as we think about guidance and the adjustment that you made, what have you pulled out in terms of the synergy for 2016? And then also as we think about 2017, with the $39 million of EBITDA that's lopping off, how should we think about your synergy expectations that you've previously given?

    各位早安,恭喜你們。第一個問題想請教 David 或 Brent:在我們看待你們的財測指引以及你們所做的調整時,2016 年的協同效益你們已經從中剔除了哪些部分?另外,展望 2017 年,隨著有 3,900 萬美元的 EBITDA 會被剔除,我們應該如何看待你們先前給出的協同效益預期?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Good morning. The synergies are completely out of the guidance for the balance of 2016, and that's roughly in the $0.08 to $0.09 range that we had previously anticipated. The outlook for consolidated cost savings, once the divestiture and the integrations occur is no different, it will be at least $20 million of synergies identified and realized, but the more reasonable expectation would be for that to occur in 2017.

    早安。2016 年剩餘期間的指引已完全不包含協同效益;這大約是我們先前預期的每股 0.08 到 0.09 美元區間。至於在完成資產剝離與整合後的合併成本節省展望並沒有改變:至少會有 2,000 萬美元的協同效益被辨識並實現,但較合理的預期是這會在 2017 年發生。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Got it. And then, Joey, as we think about the IMD, you've seen one month's worth of IMD in the system, I just wanted to get your feedback on that, and also as we think about new bed additions related to either prepare for IMD, or as we think about the outlook going forward, it seems like you've had continued success in staffing and building capacity, so is that a sustainable view, and why is it that you're able to build at 8% versus the rest of the industry, which is coming in at a lower pace?

    了解。接著,Joey,談到 IMD,你們已經在系統中看到一個月的 IMD,我想聽聽你對此的回饋。另外,關於為了因應 IMD 而新增床位,或是展望未來的新增床位,你們似乎在人力配置與擴充產能方面持續成功;這樣的趨勢是否可持續?以及為什麼你們能以 8% 的速度擴建,而產業其他公司增速較低?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Okay, Brian. First on the IMD, July is not closed out yet, so I don't have any numbers to give you on the IMD, and what we're seeing there. As I mentioned on the last conference call, give us until the end of the third quarter, and then we'll be able to talk more about the impact of the IMD beginning July 1st for the management at [Caid]. As far as building beds, we're reacting to our markets, and the needs for beds and services there, and once again, I think I've shared this with many of you, we have a very disciplined approach here at the Company, where monthly we review the anticipated bed needs of our facilities, and as you can see, we have consistently built several hundred beds every year, and with a record build this year of over 800.

    好的,Brian。先談 IMD,7 月份尚未結帳,所以我目前沒有任何 IMD 的數字可以提供,也無法說明我們看到的情況。如同我在上次電話會議提到的,請給我們到第三季末,屆時我們就能更進一步談談 IMD 自 7 月 1 日開始對 [Caid] 管理端的影響。至於建床位,我們是依據各市場以及當地對床位與服務的需求來反應。再一次,我想我已和各位多次分享:公司採取非常嚴謹的做法,每月都會檢視各院所預期的床位需求;如各位所見,我們每年都持續新增數百張床位,而今年更創下超過 800 張的紀錄。

  • But due to the size of the company, I think 800 could be the number you would see us do for next year. And we have demand for the patients and services, and so our strategy, Ron Fincher and the division President, are doing a great job meeting the needs at the local level. I will just give you one example. Our acquisition that we made in May here in Tennessee with Trust Point, within 45 days of acquiring that facility, we had already filed to double the size of the facility, that they were turning away enough patients that we believed we could build another 100 beds there. So we just happened to be in markets where the demand is rising, and we have the balance sheet and the team, and the urgency and action to build the beds.

    但由於公司規模的關係,我認為明年你們可能也會看到我們做出約 800 張的新增量。我們對病患與服務有需求,因此我們的策略是由 Ron Fincher 與事業部總裁在地方層級做得非常好,滿足當地需求。我舉一個例子:我們在田納西州於 5 月完成的 Trust Point 收購案,在取得該院所後 45 天內,我們就已提出申請要把院所規模加倍;因為他們拒收的病患數量多到我們相信可以再新增 100 張床位。所以我們剛好位於需求正在上升的市場,同時我們有資產負債表、有團隊,也有緊迫感與行動力去增建床位。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Joey, what about clinician supply, just to match the build-out?

    Joey,那臨床人員供給呢?是否足以匹配擴建速度?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • As I mentioned on previous conference calls, we several years ago started beefing up our recruitment department, and that has paid dividends for us in today's environment, in that we're able to find the clinicians we need, and that has not been an issue to us growing.

    如同我在先前的電話會議提到的,我們在幾年前就開始強化招募部門,而這在當前環境下為我們帶來了成果,使我們能找到所需的臨床人員;這並未成為我們成長的問題。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Got it. Thank you, and I'll jump back in the queue.

    了解。謝謝,我回到隊列。

  • Operator

    Operator

  • We'll go next to A.J. Rice with UBS.

    接下來請 UBS 的 A.J. Rice。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Yes, hello everybody. Maybe just first to clarify on when you can start integrating, so you've got to go out now and identify buyers I assume for these 19 facilities. Does the CMA approve your beginning to move forward with integration when you've identified the buyers, do you actually have to close the transaction? What is sort of the timeline from here?

    是的,各位好。先釐清一下你們何時可以開始整合:我想你們現在必須去找出這 19 家院所的買家。當你們已辨識出買家後,CMA 是否就會核准你們開始推進整合?還是你們必須實際完成交割?從現在起的時間表大概是怎樣?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Once we enter into a definitive agreement with the buyer, I think the CMA process allows us to start working on the cost efficiencies, so I think many times the definitive and closing are at the same time, but once we find the buyer, reach through the process and sign the definitive agreement, I think at that time the CMA will allow us to work on the cost efficiency.

    一旦我們與買方簽訂具約束力的最終協議(definitive agreement),我認為 CMA 的流程就允許我們開始著手成本效率的工作。很多時候最終協議與交割會同時發生,但一旦我們找到買方、完成流程並簽署最終協議,我認為 CMA 在那個時間點就會允許我們進行成本效率的工作。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Right. Right. And I guess you're giving yourself until the end of the year to do that, but is there any reason to think it would take that long? You've obviously got information on it. I'm just curious, is there any unusual approvals that would take that long to get the deal done or--?

    對,對。我想你們是把時間抓到年底,但有什麼理由會認為需要那麼久嗎?你們顯然已經掌握相關資訊。我只是好奇,是否有任何不尋常的核准程序會讓交易完成需要那麼久,或是——?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No, I think that we do have to go through the system, some regulatory approval process, but I think four months on the outside, I think we will be inside of the four months number, and so it won't be the end of the year. That's more like November. I think we can have it done.

    沒有。我認為我們確實需要走完系統內的一些監管核准流程,但我想以最保守來看是四個月;我認為我們會在四個月之內完成,所以不會拖到年底。比較像是 11 月左右。我認為我們可以完成。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • Okay. And then just maybe I'll ask my other follow-up on what you're seeing pricing-wise, discussions in the US about I know a lot of states have fiscal years that roll over mid-year. Anything to report there? And I think on the UK, you were down year to year in revenue per patient day about 1.9%. Is that largely mix. or what's going on in the UK pricing as well?

    好的。那我再追問一下你們看到的定價情況:美國這邊我知道很多州的財政年度會在年中更替,有沒有什麼可以回報的?另外英國方面,你們每病患日收入(revenue per patient day)年對年下降約 1.9%。這主要是組合(mix)因素嗎?還是英國的定價也有其他狀況?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • UK is mix. We did get our rate increases there that we expected, slightly more than 1%, but what you see is the mix going on, with the patient mix going on in the UK Here in the US, we do expect to get between 1% to 2% for Medicaid. You may have seen the good news that we got this morning on Medicare, that they're going to be giving us a rate increase of a net of 2.2% beginning October 1st. So once again, we think Medicaid, 1% to 2% range, and Medicare now is at 2.2%, we still expect commercial to give us 4% to 6%.

    英國是組合因素。我們確實拿到了我們預期的費率調升,略高於 1%,但你看到的是英國病患組合的變化。在美國這邊,我們預期 Medicaid 會有 1% 到 2% 的調升。你們可能也看到我們今天早上收到的好消息:Medicare 將自 10 月 1 日起給我們淨額 2.2% 的費率調升。所以再說一次,我們認為 Medicaid 在 1% 到 2% 區間,而 Medicare 現在是 2.2%;我們仍預期商業保險會給我們 4% 到 6%。

  • A.J. Rice - Analyst

    A.J. Rice - Analyst

  • All right. Great. Thanks a lot, guys.

    好。非常好。謝謝各位。

  • Operator

    Operator

  • We'll go next to Whit Mayo with Robert Baird.

    接下來請 Robert Baird 的 Whit Mayo。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Thanks. Just a couple of questions here, maybe just first for David if you could just remind us what your bank defined leverage and revolver capacity was at quarter end?

    謝謝。這裡有幾個問題,先請教 David:能否提醒我們,依銀行定義的槓桿比率(bank defined leverage)以及季末循環信貸額度(revolver)可用額度是多少?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Sure, Whit. Our leverage at the end of the quarter was right at 5.3. That does include the cross currency swap that we entered into and effect that had on our debt at the end of the quarter, and then our availability on the revolver is $150 million of the $300 million is available.

    當然,Whit。我們在季末的槓桿比率大約是 5.3。這包含我們所簽訂的交叉貨幣交換(cross currency swap),以及其在季末對我們債務的影響。另外,我們循環信貸額度 3 億美元中,可動用額度為 1.5 億美元。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Great. And I think you have some senior notes callable later this year. Just any updated thoughts around some future debt financing opportunities?

    很好。我想你們有一些高級票據(senior notes)在今年稍晚可被提前贖回(callable)。對於未來債務融資機會,有沒有任何更新的想法?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Not at this time, Whit.

    目前沒有,Whit。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Okay. And maybe one last one, just an update around some of the activity around your not for profit joint venture strategy, and how those conversations are progressing, and maybe a range for the number of partnerships you think you can get a potentially announce or put on the board in the next 12 months or so?

    好的。最後一個問題:關於你們非營利(not for profit)合資策略的一些活動進展,能否更新一下目前對話推進的情況?以及在未來 12 個月左右,你們認為可能宣布或提交董事會的合作夥伴數量大概會落在什麼範圍?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • The number and discussions are numerous. I think we could put four to six on the board between now and the end of 2017. You saw our announcement on Oschner, so we're very active in this arena and have a full page of opportunities on our pipeline.

    數量與討論都很多。我認為從現在到 2017 年底,我們可以把 4 到 6 個案子提交董事會。你們也看到我們與 Oschner 的公告,所以我們在這個領域非常積極,且我們的管線上有滿滿一頁的機會。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Maybe just remind us what the structure of some of these joint ventures look like, and then presumably you're going to have the controlling ownership interest and the governance, so just kind of curious?

    能否提醒我們這些合資案的結構大概長什麼樣子?我推測你們會擁有控股權與治理權,所以我有點好奇?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Yes. Absolutely. The first criteria for us is we need to be able to consolidate the operations, so that means we're going to own more than 50% of the partnership. We prefer to have like an 80/20, 75/25 split, with us being the 75 and 80. But it's flexible per partner. And it seems to be receptive to the not for profit systems that we're working with, and I think that will be the template going forward that you'll see with our joint ventures.

    是的,當然。對我們而言第一個標準是我們必須能夠合併報表(consolidate)其營運,因此這代表我們會持有合夥企業超過 50% 的股權。我們偏好像 80/20、75/25 這樣的分配,由我們持有 75% 或 80%。但會依合作夥伴而有彈性。看起來我們合作的非營利體系對此也相當接受,我認為這將會是未來你們會看到的合資案範本。

  • Whit Mayo - Analyst

    Whit Mayo - Analyst

  • Great. Thanks, guys.

    太好了。謝謝各位。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Thanks.

    謝謝。

  • Brent Turner - President

    Brent Turner - President

  • Thanks, Whit.

    謝謝你,Whit。

  • Operator

    Operator

  • We'll go next to John Ransom with Raymond James.

    接下來請 Raymond James 的 John Ransom 提問。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Hey, good morning. On your divestitures, is there any early read on what kind of multiple that you might expect to get for that EBITDA?

    嗨,早安。關於你們的資產剝離(divestitures),目前是否有任何初步判讀,對於這些 EBITDA 你們預期能拿到什麼樣的倍數(multiple)?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • These are great assets, and very solid EBITDA, and we think it will be a very attractive sale, and so we would be expecting to see multiples at the higher end of ranges that have been stated.

    這些都是很棒的資產,EBITDA 也非常穩健,我們認為會是一筆非常具吸引力的出售案,因此我們預期看到的倍數會落在先前所提到區間的高端。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Great. And my second question is just to reset, I heard you but I just want to make sure I got this. Other providers have complained of some NHS cuts in May and June. Can you just reset what's happening with you with UK government pricing on a go-forward basis?

    很好。我的第二個問題是想重新釐清一下,我有聽到你剛剛的說明,但我想確認我理解正確。其他服務提供者反映 5 月與 6 月 NHS 有一些削減。你能否重新說明一下,英國政府在未來(go-forward basis)的定價上,你們這邊目前是什麼狀況?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Our government pricing, we're through that process and we got more than 1% for both companies. And to my knowledge, no one from the UK has given us a heads-up here that the NHS was cutting, or trying to do something with the rate. We just negotiated ours, John, so we were not having that.

    我們的政府定價已經走完那個流程,而且兩家公司都拿到超過 1% 的調升。就我所知,英國那邊沒有人事先通知我們 NHS 要削減,或試圖對費率做任何調整。我們才剛談完我們的合約,John,所以我們沒有遇到那種情況。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Okay. That's all I have. Thank you.

    好的。我就這些。謝謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Thanks, John.

    謝謝你,John。

  • Operator

    Operator

  • We'll go next to Frank Morgan with RBC Capital Markets.

    接下來請 RBC Capital Markets 的 Frank Morgan 提問。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Good morning. The reference to the hedges related to the debt reminded me of this. Have you had any change in your hedging policy? I know your guidance contemplates the current exchange ratio, but has there been any new change above and beyond that going forward? Thanks.

    早安。你提到與債務相關的避險(hedges),讓我想到這個問題:你們的避險政策有任何改變嗎?我知道你們的指引是以目前的匯率比(exchange ratio)為前提,但往後是否有任何超出這部分的新變動?謝謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No, there's been no change from our original hedging.

    沒有,我們的避險策略與原先並無改變。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • And I believe that was roughly 40% hedged in the UK, is that correct?

    我記得英國那邊大約避險了 40%,對嗎?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • That is correct.

    沒錯。

  • Frank Morgan - Analyst

    Frank Morgan - Analyst

  • Okay. Thanks.

    好的,謝謝。

  • Operator

    Operator

  • We'll go next to Chris Rigg with Susquehanna International Group.

    接下來請 Susquehanna International Group 的 Chris Rigg 提問。

  • Chris Rigg - Analyst

    Chris Rigg - Analyst

  • Good morning. Actually, I just wanted to follow up on that last question. So what is the negative cash flow headwind because of the drop in the pound for the year?

    早安。其實我想追問剛才那個問題。那麼,今年因英鎊下跌所造成的負面現金流逆風(negative cash flow headwind)是多少?

  • David Duckworth - CFO

    David Duckworth - CFO

  • For the year, if you're just thinking about the second half of the year, it would roughly be in line with the effect that it has on our EBITDA, so I think it's about $10 million or so, if we think about the second half of the year.

    以全年來看,如果你只看下半年,影響大致會與它對我們 EBITDA 的影響一致;所以我認為下半年大約是 1,000 萬美元左右。

  • Chris Rigg - Analyst

    Chris Rigg - Analyst

  • Okay. And I guess just bigger picture, when we think about the growth in the UK, does the Priory experience sort of change the way you think about the market, or it's still a very strategic area and you should be able to acquire various assets going forward?

    好的。再從更宏觀的角度來看,當我們思考英國的成長時,Priory 的經驗是否改變了你們對市場的看法?還是英國仍然是非常具策略性的區域,你們未來仍能收購各種資產?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • We think the UK market is still very attractive, and if there's areas of acquisitions or expansions that we can make to assist the NHS and not put us in any issue with the CMA, which I think we can do, absolutely we would make acquisitions. We won't see any this year, but absolutely the UK market is still a market of opportunity, I think, and there are areas in the UK where we could go and do things that would not be a CMA issue.

    我們認為英國市場仍然非常具吸引力;如果有收購或擴張的領域,我們能夠協助 NHS,同時又不會讓我們在 CMA 上產生任何問題——我認為我們做得到——那我們絕對會進行收購。今年不會看到,但英國市場絕對仍是充滿機會的市場;我認為英國有些領域我們可以去做一些事情,而不會構成 CMA 的問題。

  • Chris Rigg - Analyst

    Chris Rigg - Analyst

  • Great. And then I heard about the bed additions for 2016, but do you have a sort of preliminary estimate for bed additions in 2017? Thanks.

    很好。然後我聽到你們提到 2016 年的床位新增(bed additions),那你們對 2017 年床位新增有沒有初步估計?謝謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • I think right now, Chris, I think right now we already have booked more than 300 beds at this time that we're working on for next year, and it will be building during the third quarter, and I'll have a better number to give you for what we're expecting in 2017 at that time.

    我想目前,Chris,我們現在已經預訂(booked)了超過 300 張床位,正在為明年推進;會在第三季期間建置。到那時我會給你一個更好的數字,說明我們對 2017 年的預期。

  • Chris Rigg - Analyst

    Chris Rigg - Analyst

  • Great. Thanks so much.

    太好了。非常感謝。

  • Operator

    Operator

  • We'll go next to Gary Lieberman with Wells Fargo.

    接下來請 Wells Fargo 的 Gary Lieberman 提問。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Good morning, thanks for taking the question. What's your expectation for the use of any capital that you raise from the sale of the Priory assets?

    早安,謝謝讓我提問。你們對出售 Priory 資產所取得的資金(capital)的用途有何預期?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Due to our pipeline and the activity there, both with joint ventures and with multi-facility opportunities, we think we will be able to redeploy that cash right back into the business, so we're very excited about being able to do that.

    由於我們的專案管線(pipeline)以及相關活動,不論是合資(joint ventures)或多機構(multi-facility)機會,我們認為能把這筆現金重新投入到業務中,因此我們對能做到這點感到非常振奮。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Okay. And then you've had some time to think about any impact from Brexit? Can you just give us your updated thoughts on what if any impact you think that's going to have on your UK business?

    好的。那你們也有一些時間思考英國脫歐(Brexit)的影響了。你能否談談你們最新的看法:你認為它對你們英國業務會有什麼影響(如果有的話)?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Well, I think everyone would agree it's kind of stabilized right now. We were over, four of our management team members were over in the 1st of July, and the UK was very, very busy, and that's just from us observing. And our facilities are very busy. So now that they've named a new Prime Minister, I think things are settling down, and I do know that the UK wants to keep all of their businesses, and recruit new businesses to the UK, so they are very much, I think, in a pro business mentality at the Parliament, so maybe we've hit the low mark there, and that we've come back a little, but I see it as being stable as of right now.

    我想大家都會同意,目前看起來已經有點穩定下來。我們管理團隊有四位成員在 7 月初到英國,我們觀察到英國非常、非常忙碌;而且我們的機構也非常忙。現在他們任命了新首相,我認為情勢正在趨於平穩。我也知道英國希望留住所有企業,並吸引新企業到英國,所以我認為國會在心態上非常親商(pro business)。因此也許我們已經觸底,並且回升了一些;但就目前而言,我認為是穩定的。

  • Gary Lieberman - Analyst

    Gary Lieberman - Analyst

  • Okay. Great. Thanks very much.

    好的。非常感謝。

  • Operator

    Operator

  • We'll go next to Ann Hynes with Mizuho Securities.

    接下來請 Mizuho Securities 的 Ann Hynes 提問。

  • Ann Hynes - Analyst

    Ann Hynes - Analyst

  • Hi, thanks. I guess since the CMA decision hasn't been made public, can you provide some detail on what the CMA's main issue was versus maybe your initial expectation, and then just a little bit more detail on the potential sale, you made the announcement yesterday that implies that it's only going to be one buyer, I guess is that what you proposed to the CMA? And just maybe the process they said they need to approve it. I know in the US, part of the process is that you have to find real buyers at competitive pricing. Do you think that's going to be a problem? Thanks.

    嗨,謝謝。我想既然 CMA 的決定尚未公開,你能否提供一些細節:CMA 的主要疑慮是什麼,和你們一開始的預期相比有何不同?另外也想再多了解一下潛在出售案:你們昨天的公告似乎暗示只會有一個買家,我想這是你們向 CMA 提出的方案嗎?以及他們說需要核准的流程。就美國而言,流程的一部分是你必須找到在具競爭性價格下的真正買家。你覺得這會是問題嗎?謝謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • We don't think it's going to be a problem. We will run a process. We will get qualified buyers. We will sign a definitive agreement in the next two to four months. I think it will be sold as one transaction. It's a very good group of assets, so I think it's going to be very attractive. And so that's kind of the process that we're going through, is running the process for these 19 facilities. We will over time give more detail, but right now that's all the detail we will give on this. It's $130 million of revenue, and it's a good group of assets.

    我們不認為會是問題。我們會跑一個流程(run a process)。我們會找到合格買家。我們會在接下來兩到四個月內簽署最終協議(definitive agreement)。我認為會以一筆交易出售。這是一組非常好的資產,所以我認為會非常有吸引力。我們正在進行的流程就是針對這 19 家機構跑出售流程。我們之後會逐步提供更多細節,但目前我們就先提供到這裡。營收是 1.3 億美元,是一組很好的資產。

  • Ann Hynes - Analyst

    Ann Hynes - Analyst

  • Okay. Thanks. And just on the, I guess a follow-up on the CMA decision, can you provide more detail on that?

    好的,謝謝。那關於 CMA 的決定,我想追問一下,你能否提供更多細節?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • The decision is two weeks ago, when they told us their decision that we may be headed to a Phase II, there was that 2-week period, I think we had five business days in order to work with the CMA on a remedy, and we did that. And then continued to work with them during the next five days. And you saw the announcement yesterday. So there was a lot of work during that two-week period. We did know areas of concern that they had, and as we worked through the process, it was a very open exchange, their concerns, our feedback to them, and then our proposal to them within the five days. And they did their announcement yesterday. And that's the process.

    這個決定是在兩週前,他們告訴我們他們的決定:我們可能會進入第二階段(Phase II)。在那之後有一個兩週期間,我想我們有五個工作天可以與 CMA 就補救措施(remedy)合作,我們也確實這麼做了。接著在接下來的五天裡持續與他們合作。然後你也看到昨天的公告。所以在那兩週期間做了很多工作。我們確實知道他們關切的領域;在我們走流程的過程中,雙方溝通非常開放——他們的疑慮、我們給他們的回饋,以及我們在五天內提出的方案。然後他們昨天做了公告。流程就是這樣。

  • Ann Hynes - Analyst

    Ann Hynes - Analyst

  • All right. I just have one more follow-up on the NHS. I think you're getting a lot of questions on it today, because they just cut pharmacy reimbursement by 6%. And I know you confirmed you're getting a 1% increase this year, but can you just describe the process of how the NHS determines funding for behavioral services, because it's my understanding it is going to get [inaudible] cuts, that each individual negotiates separately, quality plays a lot in the process. So maybe you won't be exposed to just an across the board cut like other sectors?

    好的。我還有一個關於 NHS 的追問。我想你今天被問很多次,是因為他們剛把藥局給付(pharmacy reimbursement)削減了 6%。我知道你確認你們今年拿到 1% 的調升,但你能否描述一下 NHS 如何決定對行為健康服務(behavioral services)的資金(funding)流程?因為我的理解是它會有 [inaudible] 的削減,而且每一家都是分別談判,品質在流程中也占很大比重。所以也許你們不會像其他產業一樣,面臨全面性的(across the board)削減?

  • Brent Turner - President

    Brent Turner - President

  • Well, we hope we won't be across the board cut like other sectors. There is during the process there is the local trust, and the Commissioners that get involved, and so NHS does control the money, but then they also rely upon the local areas to work with their providers in the area during the negotiations of the rating. So quality does come into play in the discussion about rates, and so this is our, I guess our second time that we've been through it with PiC. When we bought PiC, they had just went through it, and now we've done two more since then, and the first one here was Priory. And it's a very cordial process, give and take, and they very much appreciate our quality of care, and what we're doing in the UK facilities. So that is the reason our rates have just been negotiated, and it was a good process and that's been our experience for the past two years.

    嗯,我們希望不會像其他產業一樣全面被削減。在這個過程中,會有地方信託機構以及介入的專員,因此 NHS 確實掌控資金,但同時也仰賴各地方在費率談判期間與當地的服務提供者合作。所以在討論費率時,品質確實會納入考量。我想這是我們與 PiC 經歷的第二次流程。我們收購 PiC 時,他們才剛走完一次;之後我們又做了兩次,而第一次是在 Priory。這是一個非常友善、互有讓步的流程,他們也非常肯定我們的照護品質,以及我們在英國機構所做的事情。因此我們的費率才剛完成重新談判,整個過程很順利,這也是我們過去兩年的經驗。

  • Ann Hynes - Analyst

    Ann Hynes - Analyst

  • Okay. Thanks.

    好的。謝謝。

  • Operator

    Operator

  • We'll go next to Kevin Fischbeck with Bank of America.

    接下來請美國銀行的 Kevin Fischbeck 提問。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay, great, thanks. I guess I just want to go back to the psychiatrist shortage question, which we've heard a couple more hospitals seeing that. Is it your view that, in your markets, that the market for psychiatrists is pretty consistent with where it's been the last few years, or are you seeing somewhat of a shortage, it's just that the investments you made are allowing you to manage through it?

    好的,很好,謝謝。我想我只是想回到精神科醫師短缺的問題,我們也聽到有幾家醫院看到這種情況。在你們的市場裡,你們認為精神科醫師的人才市場與過去幾年大致一致,還是你們也看到某種程度的短缺,只是因為你們做的投資讓你們能夠因應?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Our investment is allowing us to address the needs of our facilities. We've got a top notch recruitment department, and working with our division Presidents and local CEOs, we're able to meet their needs, find the psychiatrists, get them signed up, get them relocated to the facilities where we need them. We're working closer and closer with residency programs on new graduates, stuff like that. So we're managing our way through this, Kevin. We identified this as a basic business strategy that we needed to do probably three years ago, and then put the resources behind that.

    我們的投資讓我們能夠滿足旗下機構的需求。我們有一個一流的招募部門,並且與各事業部總裁及各地 CEO 合作,我們能夠滿足他們的需求,找到精神科醫師,完成簽約,並把他們搬遷到我們需要他們的機構。我們也越來越密切地與住院醫師培訓計畫合作,針對新畢業生等。Kevin,我們正在設法度過這個狀況。我們大概在三年前就把這件事視為一項基本的經營策略,並投入相應資源。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay. And then as far as the guidance reduction, is it as simple as saying $0.08 to $0.09 was from the synergies delay, and then the other $0.11 or $0.12 was from the currency, or were there any other moving parts on the core business in there?

    好的。那麼就下修財測而言,是否可以簡單理解為 0.08 到 0.09 美元是來自協同效益延遲,而另外 0.11 或 0.12 美元是來自匯率?還是核心業務還有其他變動因素?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No. That is that simple. It is all of the currency and the synergies.

    沒有。就是這麼簡單。全部都是匯率和協同效益。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay. And I appreciate this being early on IMD, but is there any way to frame for us any of the kind of potential gating factors, as far as being able to see a benefit from IMD? I guess I was at an Ohio Hospital Association meeting, it sounds like Ohio is not going to be about to do the IMD for January 1. I don't know if you have any stats like that, with what percentage of your beds might be in states that are not going to July 1 necessarily move in. I'm just trying to think about how much we should reasonably expect Q3 to show, my guess is it kind of starts off pretty slow, and then ramps into 2017, it has more of an impact. I'm not sure if there were any is color on as we think about the ramp from IMD?

    好的。然後我知道 IMD 還很早期,但有沒有辦法幫我們界定一下,可能有哪些關鍵限制因素會影響我們看到 IMD 帶來的效益?我想我在俄亥俄醫院協會的一個會議上聽起來,俄亥俄州不會在 1 月 1 日就能做 IMD。我不確定你們是否有類似的統計,例如你們有多少床位所在的州不會在 7 月 1 日就跟進。我只是想思考第三季合理應該期待看到多少,我猜可能一開始很慢,然後到 2017 年逐步加速、影響更大。我不確定你們是否能提供一些關於 IMD 逐步爬坡的補充說明?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • I think the ramp does start off slow and picks up pace, and I do think January 1st, as you mentioned, will be a more key date than July 1st of this year was. However, we won't know that until we close out the third quarter and see our numbers. It's unfortunate the states aren't moving faster on that. That will be six months where people will not have access to care. But if they need to wait till January 1st, that's okay, too. We're in a position to be ready for that, also.

    我認為確實會先慢慢起步,然後加快速度;而且我也認為如你所提到的,1 月 1 日會比今年的 7 月 1 日更關鍵。不過,在我們結束第三季並看到數字之前,我們也無法確定。很可惜各州在這件事上推進不夠快。那將是六個月,民眾無法獲得照護。但如果他們需要等到 1 月 1 日也沒關係。我們也已經準備好迎接那個時間點。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • It seems like your guidance from before nothing's really changed in the core business. I don't remember that IMD had been finalized when you provided guidance last time. So --

    看起來你們先前的指引顯示核心業務其實沒有太大變化。我不記得你們上次提供指引時 IMD 已經定案了。所以——

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Our guidance has no IMD impact.

    我們的指引沒有納入 IMD 的影響。

  • Kevin Fischbeck - Analyst

    Kevin Fischbeck - Analyst

  • Okay. All right. So if there is anything, that would be it. okay. Perfect. Thanks.

    好的。明白。所以如果有任何影響,那就會是額外的。好的。非常好。謝謝。

  • Operator

    Operator

  • We'll go next to Charles Haff with Craig Hallum you mean.

    接下來請 Craig Hallum 的 Charles Haff 提問。

  • Charles Haff - Analyst

    Charles Haff - Analyst

  • All right, thanks. Following up on Kevin's question earlier, the 185 beds that you added in the second quarter was a little bit lighter than I was expecting. Is that a function of the state action that you're seeing, and maybe you're adding new beds at a little bit slower pace than you thought you would a few months ago?

    好的,謝謝。延續 Kevin 先前的問題,你們第二季新增的 185 張床位比我預期稍微少一些。這是否與你們看到的州政府動作有關,可能你們新增床位的速度比幾個月前預期的稍慢?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No, not at all. That is just the completion date of the project, and we were fortunate to have a good first quarter, and had more than 300 beds added during the first quarter. So we're very pleased, I think with the 515, and we'll hit more than 800 by the end of the year. So you should read nothing into the second quarter. It was just a completion date of the beds.

    不,完全不是。那只是專案完工日期的問題。我們第一季表現很好,也很幸運,第一季新增了超過 300 張床位。所以我們對累計 515 張非常滿意,而且到年底我們會超過 800 張。因此你不需要從第二季解讀出任何訊號;那只是床位完工的時間點。

  • Charles Haff - Analyst

    Charles Haff - Analyst

  • Okay. And then my last question is, regarding the CMA process, were there any other undertakings that Acadia offered besides the 19 divestitures, maybe investments in facilities over there, or any other undertakings besides the divestitures?

    好的。那我最後一個問題是,關於 CMA 的流程,除了 19 項資產剝離之外,Acadia 是否還提出任何其他承諾,例如在那邊的機構投資,或除了剝離以外的其他承諾?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No.

    沒有。

  • Charles Haff - Analyst

    Charles Haff - Analyst

  • Okay. Thank you.

    好的。謝謝。

  • Operator

    Operator

  • We'll go to Paula Torch with Avondale Partners.

    接下來請 Avondale Partners 的 Paula Torch 提問。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Great. Thank you. I have a couple of questions. I just wanted to follow up on the labor and psychiatrists, and maybe the capacity constraints. Winder, given that hospitals and some of your other competitors are having your capacity constraints, and you're adding 800 beds this year, and maybe potential to do a similar amount next year, do you think that gives you an opportunity to take share from your competitors, or even just the hospitals that have behavioral beds within them, given that you are able to be hiring these psychiatrists and clinicians? It seems like there are a lot of other companies having problems with this?

    很好,謝謝。我有幾個問題。我想追問一下勞動力與精神科醫師,以及可能的產能限制。Winder,鑑於醫院以及你們其他一些競爭對手正面臨產能限制,而你們今年新增 800 張床位,明年也可能新增類似數量,你認為這是否讓你們有機會從競爭對手手中取得市占,甚至從那些院內設有精神行為病床的綜合醫院取得市占,因為你們能夠聘到這些精神科醫師與臨床人員?看起來很多其他公司在這方面都有問題?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • We just executed our strategy, Paula, and if it ends up taking market share from somebody, or just being there ready for the beds and the clinicians when those patients are looking for care, either way, we're glad to be there. It will be a combination of both of those. So we're very pleased that consistently in the history of Acadia, that we've been able to build the appropriate number of beds each year, and find the clinicians to staff those beds, and to meet the needs of these local communities.

    Paula,我們只是執行我們的策略;如果最後因此從某些人手上拿到市占,或只是當病患在尋求照護時,我們能夠備妥床位與臨床人員、隨時提供服務,無論是哪一種,我們都很高興能在那裡。這兩者都會同時發生。所以我們非常滿意的是,在 Acadia 的歷史中,我們一直能夠每年建置適當數量的床位,也能找到臨床人員來配置這些床位,以滿足各地社區的需求。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Okay. And then maybe just a follow-up to that, is it possible for you to give us a little bit more color on just some of the resources that you started to put behind this three years ago? Is it just sort of higher wages or just variations to your recruiting process? I'm wondering if you could be a little more specific?

    好的。那再追問一下,你是否可以更具體說明一下,你們三年前開始投入的資源是哪些?是單純提高薪資,還是招募流程的調整?我想知道你能否更具體一點?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • You wouldn't want us to give away our trade secrets, would you? The biggest thing is, the number of people we have in our recruitment department, and the tools that we have given them, and so that is the biggest addition of resources that we have done at the corporate office. Now we do believe that we operate in attractive markets, and that our facilities look very, very good. And that if you were a clinician, and you were wanting to practice at a facility, that you would see our facilities as a facility that you would want to practice in, and so all of those things work together. And so we're just very pleased with where we're at today.

    你不會希望我們把商業機密都說出來吧?最大的重點是我們招募部門的人力規模,以及我們提供給他們的工具;這是我們在總部層級所做的最大資源投入。另外,我們也相信我們所在的市場具有吸引力,我們的機構看起來非常、非常好。如果你是一位臨床人員,想在某個機構執業,你會把我們的機構視為你想要執業的地方;這些因素共同作用。所以我們對目前的狀況非常滿意。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Great. And just one last question from me. Wanted to maybe ask on CRC, how is that business running, what are your sort of expectations for the substance use business, and are you seeing any pressure at all on reimbursement or collections from payers on that side of the business?

    很好。我最後一個問題想問 CRC,那個業務目前運作得如何?你們對物質使用(成癮)業務的預期是什麼?在那一塊,你們是否看到付款方在給付或收款上有任何壓力?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • The CRC business is doing extremely well. Extremely well. Both the substance abuse facilities, addiction facilities, and the CTC centers. And they have great growth opportunities in both areas. As I mentioned earlier, we did buy two residential addiction facilities in the second quarter, and we did buy a CTC center, and I think we opened up a de novo, too. So they're doing extremely well. Joe Pocopio and John Pellaquin, who heads up those two divisions for us are doing a great job.

    CRC 業務表現非常好,非常好。無論是物質濫用機構、成癮治療機構,還是 CTC 中心,都表現非常好,而且兩個領域都有很好的成長機會。如我先前提到的,我們在第二季收購了兩家住宿型成癮治療機構,也收購了一家 CTC 中心,我想我們也新設了一家(de novo)。所以它們表現非常好。負責這兩個事業部的 Joe Pocopio 和 John Pellaquin 做得非常出色。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • And anything on the reimbursement side?

    那在報銷方面還有什麼要補充的嗎?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No, not really. No. Now we are mostly in network, so that avoids a lot of issues.

    沒有,沒有什麼。沒有。現在我們大多都在網內,所以可以避免很多問題。

  • Paula Torch - Analyst

    Paula Torch - Analyst

  • Okay. Thank you very much.

    好的。非常感謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Okay.

    好的。

  • Operator

    Operator

  • We'll go next to Dana Hambly with Stephens.

    接下來請 Stephens 的 Dana Hambly 提問。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Hey, thanks. Good morning. Really good cash flow quarter. Over the last few years, most of your cash flow has gone towards CapEx, and just trying to get a sense, obviously a big bed add opportunity, as we look forward to the next few years, will that continue to be the case or might you deploy some cash flow maybe to delevering?

    嗨,謝謝。早安。本季現金流表現非常好。過去幾年你們大部分現金流都用在資本支出(CapEx)上;我想了解的是,顯然未來幾年有很大的增床機會,這種情況會持續嗎?還是你們可能會把部分現金流用來去槓桿、降低負債?

  • David Duckworth - CFO

    David Duckworth - CFO

  • I think you're going to see both. Obviously we're going to, the most accretive and the highest return investment we can make is on our expansion beds, but at the same time we're very cognizant of our leverage, and we're using the cash right now for a combination of reinvestment in our facilities, as well as incremental debt paydown.

    我認為你會看到兩者並行。顯然,我們能做的最具增值性、回報最高的投資,就是擴增床位;但同時我們也非常重視槓桿水準,目前我們把現金用在兩方面的組合:一是再投資於我們的設施,二是額外償還部分債務。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Okay.

    好的。

  • David Duckworth - CFO

    David Duckworth - CFO

  • That'll be the same going forward.

    未來也會是同樣的做法。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Great. The 240 beds you added in the quarter, is that neutral to EPS?

    很好。你們本季新增的 240 張床位,對 EPS 是中性的嗎?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Say that one more time?

    請再說一次?

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • The acquisitions you made in the quarter, the 240 beds, I think it was four facilities, that's basically neutral to EPS?

    你們本季做的收購,那 240 張床位,我想是四家機構,基本上對 EPS 是中性的?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Yes. Yes.

    是的。是的。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Okay. All right. And then lastly, you've talked about some of the legislation pending before, I think it made it through the House pretty easily. What's your outlook -- any chance that makes it to the President's desk this year, or is that a post-election issue?

    好的。好。最後,你們談到一些正在審議中的法案,我想它在眾議院很容易就通過了。你們的看法是——今年有機會送到總統桌上嗎?還是要等選後才會處理?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Oh, there's a good, it absolutely could be attached to a Bill. There's some good components of that legislation, obviously it didn't fully address the Medicaid IMD from a fee for service, the traditional Medicaid, but obviously we benefited on the managed Medicaid front, so I think it's imminent, in my opinion, that that's going to happen, and I think it's got a good chance of happening in late 2016, certainly, if not, early 2017 would be the point where that would go through.

    喔,有很大的機會,它絕對可能被附加在某個法案上。那項立法有一些不錯的內容;當然,它並沒有從按服務付費(fee for service)、傳統 Medicaid 的角度完整解決 Medicaid 的 IMD 問題,但我們在管理式 Medicaid 方面確實受益。所以我認為它很快就會發生;而且我覺得在 2016 年底發生的機率很高,若不是,那麼 2017 年初也很可能會通過。

  • David Duckworth - CFO

    David Duckworth - CFO

  • It probably got lost in the noise yesterday, Dana, but I think President Obama did sign the addiction bill yesterday.

    Dana,昨天可能被其他消息蓋過了,但我想歐巴馬總統昨天確實簽署了那項成癮法案。

  • Dana Hambly - Analyst

    Dana Hambly - Analyst

  • Okay. Great. Thank you.

    好的。太好了。謝謝。

  • Operator

    Operator

  • We'll go next to Ana Gupte with Leerink Partners.

    接下來請 Leerink Partners 的 Ana Gupte 提問。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Hi, thanks, good morning. Just following up again on the Priory acquisition, you may have said this, when you guided, assuming that there would not be a delay, did you already include the 19 facilities and the 750 beds in the guidance for 2016, or is this on top of what you had originally thought?

    嗨,謝謝,早安。再追問一下 Priory 收購案,你可能已經提過:你們在給出指引時、假設不會延遲的情況下,是否已經把 2016 年的指引納入這 19 家機構與 750 張床位?還是這是超出你們原先預期的額外部分?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • The earnings for the 19 facilities this year, until they're sold, they will be in our numbers, and they are in the guidance.

    這 19 家機構今年在出售之前的獲利都會計入我們的數字,而且已經包含在指引裡。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Okay. But assuming, and then when you guided for the year, and assuming this had not been delayed, were you contemplating these 19 facilities divestitures or?

    好的。但假設——你們在給出年度指引時、並假設沒有延遲,你們當時有把這 19 家機構的處分納入考量嗎?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No.

    沒有。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Okay. For next year when we think about it, that's something we need to factor in on top of what was originally contemplated then?

    好的。那明年我們在思考時,這就是我們需要在原先預期之外額外納入的因素?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Yes.

    是的。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Okay.

    好的。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Because there will be 19 less facilities. Now, as I mentioned earlier, our pipeline is very active, so the funds we receive from sales of 19 facilities, we think we can quickly, within 90 days, have that money reinvested, so we're very optimistic about being able to redeploy that capital into other acquisitions.

    因為會少 19 家機構。如我先前提到,我們的併購管線非常活躍,所以出售這 19 家機構所收到的資金,我們認為可以很快在 90 天內再投資出去;因此我們對於能把資本重新部署到其他收購案上非常樂觀。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Got it. Okay. So you can cash flow quickly. And on the synergies, sorry, on the cost side, what is the milestone on September 23rd relative to November? Are you in discussions beyond the divestitures on FT reductions, or anything that you might have to also give in on a bit?

    了解。好的。所以你們可以很快產生現金流。那在協同效益方面——抱歉,是在成本端,9 月 23 日相對於 11 月的那個里程碑是什麼?除了處分之外,你們是否也在討論全職(FT)人力縮減,或任何你們可能也需要讓步的事情?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • No, no, no. What's happening right now, until we get it sold, it's business as usual. We can't do anything on the cost efficiencies until we get CMA's clearance. And that will come when we sign the definitive agreement to sell the 19 facilities.

    沒有,沒有,沒有。目前的情況是,在賣出之前一切照常。我們在取得 CMA 核准之前,無法做任何成本效率的動作。而那會在我們簽署出售這 19 家機構的最終協議時到來。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • On your PiC business, have you now, where are you on your trajectory to the margin expansion? Is all of that done at this point? And how does that factor into the negotiation?

    關於你們的 PiC 業務,你們在利潤率擴張的進程上現在到哪裡了?到目前為止都完成了嗎?這在談判中會如何影響?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • It doesn't really factor in other than some of the PiC facilities will be, are a part of the 19 to solve the concerns and issues of the CMA, PiC is doing very well. They're same-store builds that they've been doing have done very well. And so there is still margin opportunity there, but PiC is doing very well.

    它其實不太影響,除了部分 PiC 機構會納入那 19 家之中,以解決 CMA 的疑慮與問題。PiC 表現非常好;他們做的同店擴建(same-store builds)成效也很好。所以那裡仍有利潤率提升的機會,但 PiC 目前運作得很不錯。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Okay. And then similarly on the CRC, is there margin opportunity on that side of it as well?

    好的。那同樣地,在 CRC 方面,那邊也有利潤率提升的機會嗎?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • On the CRC side? Only on the new acquisitions that we buy. Ron and his team are doing a very good job running those facilities.

    CRC 方面嗎?只有在我們買進的新收購案上才有。Ron 和他的團隊在營運那些機構方面做得非常好。

  • Ana Gupte - Analyst

    Ana Gupte - Analyst

  • Got it. Okay. Well, thank you. Appreciate it.

    了解。好的。謝謝。很感謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Thank you.

    謝謝。

  • Operator

    Operator

  • We'll take a follow-up question from Brian Tanquilut with Jefferies.

    我們接著接受 Jefferies 的 Brian Tanquilut 的追問。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Hey, guys, thanks for taking a follow-up. David, on the P&L, professional fees were up about roughly $11 million sequentially, or $10 million sequentially. Is there any reason for that we should be aware of?

    嗨,各位,謝謝讓我追問。David,就損益表來看,專業費用(professional fees)較前一季增加約 1,100 萬美元,或約 1,000 萬美元。這有什麼原因是我們需要注意的嗎?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Yes, Brian, what we see there, and this is true for a few other lines as well, is just the effect of having Priory for a full quarter. We see certain line items increasing, rent may be another one that you may notice, but that's for the most part driving the change that you see.

    是的,Brian,我們看到的情況——而且這對其他幾個科目也一樣——主要是 Priory 完整一季入帳的影響。我們看到某些科目增加,租金可能也是你會注意到的另一項,但大致上就是這個因素驅動你看到的變化。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Now are you backing out the incremental, or kind of like nonrecurring expenses related to the CMA review, in terms of like lawyers fees, and things like that?

    那你們是否把與 CMA 審查相關的增量、或類似一次性費用(例如律師費等)剔除?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Yes, those types of items would be included in our transaction-related expenses.

    是的,這類項目會包含在我們的交易相關費用(transaction-related expenses)中。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Got it. And then free cash flow is the strongest we've seen in the history of the Company. So how should we think about that in terms of the sustainability, taking out the impact of FX beginning in Q3?

    了解。那自由現金流是我們在公司歷史上看到最強的一次。那我們該如何看待其可持續性,並且在第三季開始剔除匯率(FX)影響之後?

  • David Duckworth - CFO

    David Duckworth - CFO

  • Yes, we expect the number to be similar to what we've reported for the second quarter. We do see the timing of interest payments having about a $20 million impact in the third quarter that we should benefit from, and the fourth quarter. And just one clarification on the FX impact. We do have 40% of our cash flows from the UK hedged through the cross currency swaps, and so we have flexibility on when we complete those transfers, and we do have some protection and fixed transfers set up already at about a 1.45 rate. So we expect operating cash flows to continue to be strong, above $100 million a quarter.

    是的,我們預期該數字會與我們第二季所報告的水準相近。我們確實看到利息支付時點在第三季會帶來約 2,000 萬美元的影響,讓我們在第三季與第四季受益。另外針對匯率影響補充說明:我們透過交叉貨幣交換(cross currency swaps)對英國來源的 40% 現金流做了避險,因此我們在完成那些資金移轉的時間點上有彈性;而且我們也已經在約 1.45 的匯率水準設定了一些保護與固定移轉。所以我們預期營運現金流會持續強勁,每季超過 1 億美元。

  • Brian Tanquilut - Analyst

    Brian Tanquilut - Analyst

  • Wow. Okay. Got it. All right. Thanks, guys.

    哇。好的。了解。好,謝謝各位。

  • Operator

    Operator

  • And we'll take our final question from John Ransom with Raymond James.

    我們最後一個問題來自 Raymond James 的 John Ransom。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Hey, Joey, just back on your pipeline, you've mentioned before US psych deals, just approximately how many deals are bubbling around that might be more than, say five facilities that you're looking at actively?

    嗨,Joey,回到你們的併購管線,你之前提到美國精神科(psych)交易;大概有多少案子正在醞釀中,而且是你們正在積極評估、規模可能超過例如五家機構的?

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • There's probably three to five.

    大概有三到五個。

  • John Ransom - Analyst

    John Ransom - Analyst

  • Great. Thanks.

    很好,謝謝。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Thanks.

    謝謝。

  • Operator

    Operator

  • And with no additional questions, I'll turn the call back to Joey Jacobs for closing comments.

    如果沒有其他問題,我將把電話交回 Joey Jacobs 作結語。

  • Joey Jacobs - Chairman, CEO

    Joey Jacobs - Chairman, CEO

  • Thanks everyone for their interest in Acadia. I know we spent most of the time talking about financial and processes that we do on the business side, but I do want to thank all our employees and clinicians in the field, for their dedication to our patients, and getting them better, and working with their families. That's what makes Acadia successful, is delivering quality care to our patients, and the families, and it takes, we now have over 35,000 employees now, and it takes a lot of effort, and I very much recognize every day the work you all do in the field, taking care of our patients. So once again, thank you for what you're doing. Thank you all for your interest in Acadia, and we'll talk to you at the next quarter.

    感謝各位對 Acadia 的關注。我知道我們大部分時間都在談財務以及我們在業務端所做的流程,但我也想感謝我們在第一線的所有員工與臨床人員,感謝你們對病患的投入,幫助他們康復,並與他們的家屬一起合作。Acadia 之所以成功,就在於為病患與家屬提供高品質照護;而這需要大量努力。我們現在已有超過 35,000 名員工,我每天都非常認可各位在第一線所做的工作,照顧我們的病患。所以再次感謝你們所做的一切。也謝謝大家對 Acadia 的關注,我們下個季度再與各位交流。

  • Operator

    Operator

  • Thank you, sir. Again that does conclude today's conference. Thank you to everyone for participating. You may disconnect at this time.

    謝謝您,先生。再次提醒,今天的電話會議到此結束。感謝各位參與。您現在可以掛線。